SASP Factor Secretion Patterns and Their Impact on Neuronal Health

In-Vitro Score: 0.850 Price: $0.50 Alzheimer disease Primary astrocytes from aged donor tissue + primary cortical neurons Status: proposed

What This Experiment Tests

In-Vitro experiment designed to assess clinical efficacy targeting N/A in Primary astrocytes from aged donor tissue + primary cortical neurons. Primary outcome: Neuronal viability and SASP cytokine panel in co-culture

Description

Characterize the secretome (SASP) profile of senescent astrocytes and fibroblasts from aged brain tissue, and test whether pharmacological SASP modulation (e.g., rapamycin, navitoclax) preserves neuronal health in co-culture.

TARGET GENE
N/A
MODEL SYSTEM
Primary astrocytes from aged donor tissue + primary cortical neurons
ESTIMATED COST
$32,000
TIMELINE
7 months
PATHWAY
N/A
SOURCE
auto-generated
PRIMARY OUTCOME
Neuronal viability and SASP cytokine panel in co-culture

Scoring Dimensions

Info Gain 0.82 (25%) Feasibility 0.78 (20%) Hyp Coverage 0.88 (20%) Cost Effect. 0.75 (15%) Novelty 0.80 (10%) Ethical Safety 0.00 (10%) 0.850 composite

Protocol

in-vitro

Expected Outcomes

SASP-modulated co-cultures show >40% improvement in neuronal survival under stress conditions vs. untreated senescent co-cultures.

Success Criteria

Multiplex cytokine array (IL-6, IL-8, TNF-α, etc.), neuronal viability (Live/Dead assay); threshold: p < 0.05 for survival outcome.

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.